Overview Drugs/Antibodies Mechanism of Action Toxicity Hydroxyurea Inhibits ribonucleotide reductase GI upset and myelosupression Trastuzumab Anti-HER-2 (erb-B2) monoclonal antibody Cardiotoxicity Tamoxifen and raloxifene Selective estrogen receptor modulator ↑ risk of endometrial carcinoma and hot flashes Imatinib bcr-abl tyrosine kinase inhibitor Fluid retention Rituximab anti-CD20 monoclonal antibody - Vemurafenib Inhibitor of BRAF Hydroxyurea Mechanism inhibits ribonucleotide reductase leads to decreased DNA synthesis S-phase specific Clinical use melanoma CML sickle cell disease via increased HbF Toxicity myelosuppression GI upset Trastuzumab (Herceptin) Mechanism anti-HER-2 (erb-B2) monoclonal antibody Clinical use HER-2 positive breast cancer Toxicity cardiotoxicity Tamoxifen, raloxifene Mechanism selective estrogen receptor modulator (SERM) estrogen antagonist in estrogen receptor-positive breast cancer cells estrogen agonist in other tissues bone Clinical use breast cancer prevent osteoporosis Toxicity ↑ risk of endometrial carcinoma tamoxifen only via partial agonist effects raloxifene is endometrial antagonist hot flashes Imatinib (Gleevec) Mechanism Philadelphia chromosome bcr-abl tyrosine kinase inhibitor t(9;22) translocation Clinical use CML GI stromal tumors Toxicity fluid retention Rituximab Mechanism anti-CD20 monoclonal antibody most B cell neoplasms are CD20 positive Clinical use non-Hodgkin's lymphoma chronic lymphocytic leukemia rheumatoid arthritis with methotrexate
QUESTIONS 1 of 4 1 2 3 4 Previous Next Sorry, this question is for PEAK Premium Subscribers only Upgrade to PEAK Sorry, this question is for PEAK Premium Subscribers only Upgrade to PEAK Sorry, this question is for PEAK Premium Subscribers only Upgrade to PEAK Sorry, this question is for PEAK Premium Subscribers only Upgrade to PEAK
All Videos (1) Login to View Community Videos Login to View Community Videos Rituximab Mnemonic for USMLE Oncology - Targeted Therapy D 8/22/2019 97 views 5.0 (1)